Highly pathogenic H5N1 avian influenza virus: Cause of the next pandemic?

Comparative Immunology, Microbiology and Infectious Diseases

Volumn 32, Issue 4, 2009, Pages 287-300

  Pappaioanou, Marguerite ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Avian influenza; H5N1; Influenza; Pandemic

Indexed keywords

ADAMANTANE DERIVATIVE; ANTIVIRUS AGENT; INACTIVATED VACCINE; INFLUENZA VACCINE; OSELTAMIVIR; SIALIDASE INHIBITOR; SUBUNIT VACCINE; ZANAMIVIR;

AFRICA; ARTICLE; ASIA; AVIAN INFLUENZA; BIRD; CLINICAL TRIAL; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; EPIDEMIC; EUROPE; HONG KONG; HUMAN; INFECTION PREVENTION; INFLUENZA VIRUS A H5N1; LABORATORY DIAGNOSIS; MIDDLE EAST; MOLECULAR EVOLUTION; MORBIDITY; MORTALITY; NONHUMAN; PANDEMIC; POULTRY; RISK REDUCTION; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TRANSMISSION; VIRUS VIRULENCE; WILD ANIMAL; WORLD HEALTH ORGANIZATION;

ANIMALS; ANTIVIRAL AGENTS; BIRDS; DISEASE OUTBREAKS; DISEASE RESERVOIRS; EPIDEMIOLOGY, MOLECULAR; EVOLUTION, MOLECULAR; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA VACCINES; INFLUENZA, HUMAN; RECEPTORS, CELL SURFACE; WORLD HEALTH;

AVES; AVIAN INFLUENZA VIRUS; INFLUENZA A VIRUS;

EID: 62549105755     PISSN: 01479571     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cimid.2008.01.003     Document Type: Article

References (111)

1. Kilbourne E.D. Influenza pandemics of the 20th century. Emerg Infect Dis 12 (2006) 9-14
2. Osterholm M. Preparing for the next pandemic. Foreign Aff (July/August 2005)
3. CDC. Update: isolation of avian influenza A (H5N1) viruses from humans-Hong Kong, 1997-1998. MMWR 46 (1998) 1245-1247
4. Osterholm M.T. Preparing for the next pandemic. N Engl J Med 352 (2005) 1839-1842
5. WHO. Cumulative number of confirmed human cases of avian influenza A/(H5N1) reported to WHO; 2006. Accessed online March 1, 2007: http://www.who.int/csr/disease/avian_influenza/country/cases_table_2007_03_01/en/index.html.
6. The Writing Committee of the World Health Organization. Avian Influenza A (H5N1) infection in humans. N Engl J Med 353 (2005) 1374-1385
7. WHO. Epidemiology of WHO-confirmed human cases of avian influenza A (H5N1) infection. WER 81 (2006) 249-257
8. OIE. Update on avian influenza in animals (Type H5), as of June 20, 2007. Accessed on line March 4, 2007 at: http://www.oie.int/downld/AVIAN%20INFLUENZA/Graph%20HPAI/graphs%20HPAI%2002_03_2007.pdf.
9. CDC. Avian influenza in humans. Accessed online January 20, 2007 at: http://www.cdc.gov/flu/avian/gen-info/avian-flu-humans.htm.
10. Ungchusak K., Auewarakul P., Dowell S.F., et al. Probable person-to-person transmission of avian influenza A (H5N1). N Engl J Med 352 (2005) 333-340
11. Kandun I.N., Wibisono H., Sedyaningsih E.R., et al. Three Indonesian clusters of H5N1 virus infection in 2005. N Engl J Med 355 21 (2006) 2186-2194
12. WHO. Current WHO phase of pandemic alert. Accessed online January 20, 2007 at: http://www.who.int/csr/disease/avian_influenza/phase/en/index.html.
13. National vaccine program office. Influenza pandemics: how they start, how they spread, and their potential impact. Accessed online January 20, 2007 at: http://www.hhs.gov/nvpo/pandemics/flu2.htm#3.
14. Webster R.G., Bean W.J., Gorman O.T., Chamgers T.M., et al. Evolution and ecology of influenza A viruses. Microbiol Rev 56 (1992) 152-179
15. Belshe R.B. The origins of pandemic influenza-lessons from the 1918 virus. N Engl J Med 353 (2005) 2209-2211
16. Taubenberger J.K., Reid A.H., Lourens R.M., et al. Characterization of the 1918 influenza virus polymerase genes. Nature 437 (2005) 889-893
17. Yamada S., Suzuki Y., Suzuki T., et al. Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses. Nature 444 (2006) 378-382
18. Kawaoka Y., Krauss S., and Webster R.G. Avian-to-human transmission of the Pb1 gene of influenza A viruses in the 1957 and 1968 pandemics. J Virol 63 (1989) 4603-4608
19. Neumann G., and Kawaoka Y. Host range restriction and pathogenicity in the context of influenza pandemic. Emerg Infect Dis 12 6 (2006) 881-886
20. Chen J., Lee K.H., Steinhauer D.A., Stevens D.J., et al. Structure of the hemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation. Cell 95 (1998) 409-417
21. Subbarao K., and Katz J. Avian influenza viruses infecting humans. Cell Mol Life Sci 57 (2000) 1770-1784
22. Fouchier R.A.M., Munster V., Wallensten A., et al. Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J Virol 79 (2005) 2814-2822
23. Subbarao K., Klimov A., Katz J., et al. Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science 279 (1998) 393-396
24. Crawford P.C., Dubovi E.J., Castleman W.L., et al. Transmission of equine influenza virus to dogs. Science 310 (2005) 482-485
25. Keawcharoen J., Oraveerakul K., Kuiken T., et al. Avian influenza H5N1 in tigers and leopards. Emerg Infect Dis 10 (2004) 2189-2191
26. PAHO. Avian influenza virus A (H10N7) circulating among humans in Egypt. EID Weekly updates. Accessed online January 21, 2007 at: http://www.paho.org/English/AD/DPC/CD/eid-eer-07-may-2004.htm.
27. Lin Y.P., Shaw M., Gregory V., et al. Avian-to-human transmission of H9N2 subtype influenza A viruses: relationship between H9N2 and H5N1 human isolates. Proc Natl Acad Sci USA 97 (2000) 9654-9658
28. Koopmans M., Wilbrink B., Conyn M., et al. Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands. Lancet 363 9409 (2004) 587-593
29. Gill J.S., Webby R., Gilchrist M.J.R., and Gray G.C. Avian influenza among waterfowl hunters and wildlife professionals. Emerg Infect Dis 12 (2006) 1284-1286
30. Zhou N.N., Senne D.A., Landgraf J.S., et al. Genetic reassortment of avian, swine, and human influenza A viruses in American pigs. J Virol 73 (1999) 8851-8856
31. Peiris J.S.M., Guan Y., Markwell D., et al. Cocirculation of avian H9N2 and contemporary "human" H3N2 influenza A viruses in pigs in southeastern China: potential for genetic reassortment. J Virol 75 (2001) 9679-9686
32. Songserm T., Amonsin A., Jam-on R., et al. Avian influenza H5N1 in naturally infected domestic cat. Emerg Infect Dis 12 (2006) 681-683
33. Amonsin A., Payungporn S., Theamboonlers A., et al. Genetic characterization of H5N1 influenza A viruses isolated from zoo tigers in Thailand. Virology 344 (2006) 480-491
34. Songserm T., Amonsin A., Jam-on R., et al. Fatal avian influenza A H5N1 in a dog. Emerg Infect Dis 12 (2006) 1744-1747
35. WHO. Avian influenza-H5N1 infection found in a stone marten in Germany. Accessed online January 21, 2007 at: http://www.who.int/csr/don/2006_03_09a/en/index.html.
36. Wells D.L., Hopfensperger D.J., Arden N.H., et al. Swine influenza virus infections: transmission from ill pigs to humans at a Wisconsin agricultural fair and subsequent probable person-to-person transmission. J Am Med Assoc 265 (1991) 478-481
37. Rimmelzwaan G.F., de Jong J.C., Bestebroer T.M., et al. Antigenic and genetic characterization of swine influenza A (H1N1) viruses isolated from pneumonia patients in the Netherlands. Virology 282 (2001) 301-306
38. Webby R., Hoffman E., and Webster R. Molecular constraints to interspecies transmission of viral pathogens. Nat Med Suppl 10 (2004) S77-S81
39. Harvey R., Martin A.C.R., Zambon M., and Barclay W.S. Restrictions to the adaptation of influenza A virus H5 hemagglutinin to the human host. J Virol 78 (2004) 502-507
40. Couceiro J.N., Paulson J.C., and Baum L.G. Influenza virus strains selectively recognize sialyloligosaccharides on human respiratory epithelium; the role of the host cell in selection of hemagglutinin receptor specificity. Virus Res 29 (1993) 155-165
41. Connor R.J., Kawaoka Y., Webster R.G., and Paulson J.C. Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates. Virology (2005) 17-23
42. Uiprasertkul M., Puthavathana P., Sangsiriwut K., et al. Influenza A H5N1 replication sites in humans. Emerg Infect Dis 11 (2006) 1036-1041
43. Rogers G.N., Paulson J.C., Daniels R.S., et al. Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity. Nature 304 (1983) 76-78
44. Stevens J., Blixt O., Tumpey T.M., Taubenberger J.K., et al. Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science 312 (2006) 404-410
45. Glaser L., Stevens J., Zamarin D., et al. A single amino acid substitution in the 1918 influenza virus hemagglutinin changes the receptor binding specificity. J Virol 79 (2005) 11533-11536
46. Matrosovich M.N., Matrosovich T.Y., Gray T., et al. Human and avian influenza viruses target different cell types in cultures of human airway epithelium. Proc Natl Acad Sci USA 101 (2004) 4620-4624
47. Shinya K., Ebina M., Yamada S., et al. Influenza virus receptors in the human airway. Nature 440 (2006) 435-436
48. Garten W., and Klenk H.D. Understanding influenza virus pathogenicity. Trends Microbiol 7 (1999) 99-100
49. Kawaoka Y., Naeve C.W., and Webster R.G. Is virulence of H5N2 influenza viruses in chickens associated with loss of carbohydrate from the hemagglutinin?. Virology 139 (1984) 303-316
50. Nicholls JM, Chan MCW, Chan WY, et al. Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract. Nat Med, Published online January 7, 2007.
51. Matrosovich M., Tuzikov A., Bovin N., et al. Early alterations of the receptor-binding properties of H1, H2, and H3 avian influenza virus hemagglutinins after their introduction into mammals. J Virol 74 (2000) 8503-8512
52. Tran T.H., Liem N.T., Dung N.T., et al. Avian influenza A (H5N1) in 10 patients in Vietnam. N Engl J Med 350 (2004) 1179-1188
53. Yuen K.Y., Chan P.K., Peiris M., et al. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 351 February 14 (9101) (1998) 467-471
54. Chotpitayasunondh T., Ungchusak K., Hanshaoworakul W., et al. Human disease from influenza A (H5N1), Thailand, 2004. Emerg Infect Dis 11 (2005) 201-209
55. Oner A.F., Bay A., Arslan S., et al. Avian influenza A (H5N1) infection in eastern Turkey in 2006. N Engl J Med 355 21 (2006) 2179-2185
56. WHO. Recent findings countering genetics angle.
57. Bosch F.X., Garten W., Klenk H.D., and Rott R. Proteolytic cleavage of influenza virus hemagglutinins: primary structure of the connecting peptide between HA1 and HA2 determines proteolytic cleavability and pathogenicity of avian influenza viruses. Virology 113 (1981) 725-735
58. Tumpey T.M., Basler C.F., Aguilar P.V., et al. Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science 310 (2005) 77-80
59. De Jong M.D., Simmons C.P., Thanh T.T., et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 12 (2006) 1203-1207
60. Cheung C.Y., Poon L.L., Lau A.S., et al. Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?. Lancet 360 (2002) 1831-1837
61. Chan M.C.W., et al. Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveoplar and bronchial epithelial cells. Respir Res 6 (2005) 135. http://respiratory-research.com/content/6/1/135 (Available online from http://respiratory-research.com/content/6/1/135)
62. Guan Y., Poon L.L.M., Cheung C.Y., et al. H5N1 influenza: A protean pandemic threat. Proc Natl Acad Sci USA 101 (2004) 8156-8161
63. Geiss G.K., Salvatore M., Tumpey T.M., et al. Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: the role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza. Proc Natl Acad Sci USA 99 (2002) 10736-10741
64. Kobasa D., Takada A., Shinya K., et al. Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus. Nature 431 (2004) 703-707
65. Kash J.C., Basler C.F., Garcia-Sastre A., et al. Global host immune response: pathogenesis and transcriptional profiling of type A influenza viruses expressing the hemagglutinin and neuraminidase genes from the 1918 pandemic virus. J Virol 78 (2004) 9499-9511
66. Bender C., Hall H., Huang J., et al. Characterization of the surface proteins of influenza A (H5N1) viruses isolated from humans in 1997-1998. Virology 254 (1999) 115-123
67. Xu Y.Y., Subbarao K., Cox N.J., and Guo Y.J. Genetic characteristics of the pathogenic influenza A/Goose/Guangdong//1/96 (H5N1) virus: similarity of its hemagglutinin gene to those of H5N1 viruses from the 1997 outbreaks in Hong Kong. Virology 261 (1999) 15-19
68. Guan Y., Shortridge K.F., Krauss S., and Webster R.G. Molecular characterization of H9N2 influenza viruses: were they the donors of the "internal" genes of H5N1 viruses in Hong Kong?. Proc Natl Acad Sci USA 96 (1999) 9363-9367
69. Subbarao K., and Shaw M.W. Molecular aspects of avian influenza (H5N1) viruses isolated from humans. Rev Med Virol 10 (2000) 337-348
70. Sims L.D., Ellis T.M., Liu K.K., et al. Avian influenza in Hong Kong 1997-2002. Avian Dis 47 3 Suppl (2003) 832-838
71. Li K.S., Guan Y., Wang J., et al. Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia. Nature 430 (2003) 209-213
72. WHO. WHO Global Influenza Program Surveillance Network. Evolution of HN1 avian influenza viruses in Asia. Emerg Inf Dis 11 (2005) 1515-1521
73. WHO. Influenza research at the human and animal interface. Report of a WHO working group. Geneva, Switzerland, September 21-22, 2006. WHO/CDS/EPR/GIP/2006.3. Accessed on line January 23, 2007 at: http://www.who.int/csr/resources/publications/influenza/WHO_CDS_EPR_GIP_2006_3C.pdf.
74. Webser R.G., and Govorkova E.A. H5N1 influenza-evolving evolution and spread. N Engl J Med 355 (2006) 2174-2177
75. Smith G.J.D., Fan X.H., Wang J., et al. Emergence and predominance of an H5N1 influenza variant in China. Proc Natl Acad Sci USA 103 (2006) 16936-16941
76. Hulse-Post D.J., Surm-Ramirez K.M., Seiler H.P., et al. Role of domestic ducks in the propagation and biological evolution of highly pathogenic H5N1 influenza viruses in Asia. Proc Natl Acad Sci USA 102 (2005) 10682-10687
77. Sturm-Ramirez K.M., Ellis T., Bousfield B., Bissett L., et al. Reemerging H5N1 influenza viruses in Hong Kong in 2002 are highly pathogenic to ducks. J Virol 78 (2004) 4892-4901
78. Chen H., Deng G., Li Z., et al. The evolution of H5N1 influenza viruses in ducks in southern China. Proc Natl Acad Sci USA 101 (2004) 10452-10457
79. Gilbert M., Chaitaweesub P., Parakamawongsa T., et al. Free-grazing ducks and highly pathogenic avian influenza, Thailand. Emerg Infect Dis 12 (2006) 227-234
80. Luke C.J., and Subbarao K. Vaccines for pandemic influenza. Emerg Infect Dis 12 (2006) 66-72
81. Subbarao K., Murphy B.R., and Fauci A.S. Development of effective vaccines against pandemic influenza. Immunity 24 (2006) 5-9
82. Promed. Avian Influenza (14): Viet Nam, Thailand, South Korea. Ducks in Vietnamese province infected with bird flu. Posted January 22, 2007. Archive Number 20070122.0295; Accessed on line January 29, 2007 at: http://www.promedmail.org/pls/promed/f?p=2400:1001:7219590730279528404::NO::F2400_P1001_BACK_PAGE,F2400_P1001_PUB_MAIL_ID:1010,36018.
83. Choi Y.K., Nguyen T.D., Ozaki H., et al. Studies of H5N1 influenza virus infection of pigs by using viruses isolated in Vietnam and Thailand in 2004. J Virol 79 (2005) 10821-10825
84. Webser R., and Hulse D. Controlling avian flu at the source. Commentary. Nature 435 (2005) 415-416
85. OIE. Recommendations. OIE/FAO international scientific conference on avian influenza, OIE, Paris, France, April 7-8, 2005. Accessed on line January 22, 2007 at: http://www.oie.int/eng/avian_influenza/OIE_FAO_Recom_05.pdf.
86. Perdue M.L., and Swayne D.E. Public health risk from avian influenza viruses. Avian Dis 49 (2005) 317-327
87. Capua I., and Marangon S. Control of avian influenza in poultry. Emerg Infect Dis 12 (2006) 1319-1324
88. FAO/OIE/WHO Technical consultation on the control of avian influenza. February 3-4, 2004, conclusions and recommendations. Accessed on line January 22, 2007 at: http://www.oie.int/downld/AVIAN%20INFLUENZA/avian_rome_feb04_report.pdf.
89. USDA. USDA Fact sheet (Release No. 0458.05). Questions and answers; March 2006. Accessed online January 22, 2007 at: http://www.usda.gov/wps/portal/!ut/p/_s.7_0_A/7_01RD?printable=true&contentidonly=true&contentid=2005/10/0458.xml.
90. Dinh P.N., Long H.T., Tien N.T., et al. Risk factors for human infection with avian influenza A H5N1, Vietnam, 2004. Emerg Infect Dis 12 (2006) 1841-1847
91. Sturm-Ramirez K.M., Hulse-Post D.J., Govorkova E.A., et al. Are ducks contributing to the endemicity of highly pathogenic H5N1 influenza virus in Asia?. J Virol 79 (2005) 11269-11279
92. WHO. Avian influenza ("bird flu")-Fact sheet; January 2006. Accessed on line January 22, 2007 at: http://www.who.int/csr/disease/avian_influenza/avianinfluenza_factsheetJan2006/en/print.html.
93. Schünemann H.J., Hill S.R., Kakad M., et al. WHO rapid advice guidelines for pharmaceutical management of sporadic human infection with avian influenza A (H5N1) virus. Lancet Infect Dis 7 (2007) 21-31
94. CDC. Interim guidance for protection of persons involved in U.S. avian influenza outbreak disease control and eradication activities. Accessed online January 29, 2007 at: http://www.cdc.gov/flu/avian/professional/protect-guid.htm.
95. CDC. Avian influenza: protecting workers from exposure. Accessed online January 29, 2007 at: http://www.cdc.gov/niosh/topics/avianflu/.
96. CDC. Prevention and control of influenza: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep 55 (2006) 1-42
97. FDA. Personal protective equipment and influenza outbreaks, including bird flu (avian influenza). Accessed online January 29, 2007 at: http://www.fda.gov/cdrh/ppe/fluoutbreaks.html.
98. US Department of Labor, Occupational Safety & Health Administration. Guidelines for protecting workers against avian influenza. Accessed online January 29, 2007 at: http://www.osha.gov/dsg/guidance/avian-flu.html.
99. Department of Interior. Employee health and safety guidance for avian influenza surveillance and control activities in wild bird populations. Memorandum, January 2007. Accessed online January 29, 2007 at: http://www.doi.gov/issues/appendixOHSguidanceforAvian%20Influenza12-18.pdf.
100. Saenz R.A., Hetgcite H.W., and Gray G. Confined animal feeding operations as amplifiers of influenza. Vector Borne Zoonot 4 (2006) 338-346
101. WHO. Antigenic and genetic characteristics of H5N1 viruses and candidate H5N1 vaccine viruses developed for potential use as pre-pandemic vaccines. Accessed on line January 23, 2007 at: http://www.who.int/csr/disease/avian_influenza/guidelines/recommendationvaccine.pdf.
102. Center for Infectious Disease and Research. FDA panel supports H5N1 vaccine approval. February 27, 2007. Accessed on line March 4, 2007 at: http://www.cidrap.umn.edu/cidrap/content/influenza/avianflu/news/feb2707vaccine.html.
103. Monto A.S. Vaccine and antiviral drugs in pandemic preparedness. Emerg Infect Dis 12 (2006) 55-60
104. de Jong M.D., Tran T.T., Khanh T.H., et al. Oseltamivir resistance during treatment of influenza A (H5N1) infection. N Engl J Med 353 (2005) 2667-2672
105. WHO. Advice on use of oseltamivir; March 17, 2006. Accessed on line January 29, 2007 at: http://www.who.int/csr/disease/avian_influenza/guidelines/useofoseltamivir2006_03_17A.pdf.
106. Moscona A. Oseltamivir resistance-disabling our influenza defenses. N Engl J Med 353 (2005) 2633-2636
107. WHO Writing Group. Nonpharmaceutical interventions for pandemic influenza, international measures. Emerg Inf Dis 12 (2006) 81-87
108. Glass R.J., Glass L.M., Beyeler W., and Min H.J. Targeted social distancing design for pandemic influenza. Emerg Inf Dis 12 (2006) 1671-1681
109. Chen H., Smith G.J., Li K.S., et al. Establishment of multiple sublineages of H5N1 influenza virus in Asia: implications for pandemic control. Proc Natl Acad Sci USA 103 (2006) 2845-2850
110. Kilpatrick A.M., Chmura A.A., Gibbons D.W., et al. Predicting the global spread of H5N1 avian influenza. Proc Natl Acad Sci USA 103 (2006) 19368-19373
111. WHO. Avian influenza and human pandemic influenza. Summary report. Meeting held in Geneva, Switzerland, November 7-9, 2005. Accessed on line January 29, 2007 at: http://www.who.int/mediacentre/events/2005/avian_influenza/summary_report_Nov_2005_meeting.pdf.